McDermott Will & Emery lawyer Emily J. Cook recently spoke to Bloomberg Law about a drug alternative dispute resolution (ADR) process that’s on hold after the Biden administration removed its Trump administration appointees. This particular process concerns Department of Health and Human Services panelists that will determine the direction of a 340B drug review board.
Drug Discount Fights in Limbo Until Biden Restores Review Board
By Emily J. Cook on May 26, 2021
Posted In Employee Benefits, Health and Welfare Plans
Emily J. CookIn today’s complex and fast-changing healthcare regulatory environment, Emily Jane Cook helps healthcare organizations thrive. Innovative start-ups and established market leaders alike turn to Emily for broad-spectrum strategies to fuel new business initiatives and solve their most pressing compliance, transactional, reimbursement and litigation challenges. Emily is a practice area leader for the Healthcare Regulatory & Compliance practice. In addition to Emily’s role as a national authority on the 340B drug pricing program, Emily helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. She partners with a wide range of organizations, including non-traditional service providers and new market entrants to identify, protect and expand revenue opportunities, including via private-equity-backed ventures. Her comprehensive counsel encompasses evolving issues such as No Surprises Act (NSA) implementation, development of new provider types, Medicare provider-based and co-location rules, and trends in qui tam litigation and government investigations. She works closely with colleagues in McDermott’s transactional, litigation and private equity practices to deliver fully realized solutions for her clients. Read Emily Cook's full bio.
Related Posts
- Senate Approves Resolution to End COVID-19 National Emergency Declaration
- See What’s Next with McDermott+Consulting’s 340B Ligitation Tracking Tool
- IRS Expands Scope of Preventive Care Under Health Savings Account Rules
- 2024 Chart of Healthcare Regulations
- HHS Publishes New Rights of Conscience Final Rule
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- CMS Issues Guidance on Usage of AI in Making Coverage Determinations
- 2024 Chart of Healthcare Regulations
- Potential Election Year Shakeup: Regulatory Implications of the Congressional Review Act
- Lessons from Ryan S. v. UnitedHealth Group for the 2023 MHPAEA Proposed Rule
- Hospital Settles With OCR for $4.75 Million Over HIPAA Violations
